Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ani Pharmaceuticals (ANIP) Current Deferred Tax Assets: 2014

Historic Current Deferred Tax Assets for Ani Pharmaceuticals (ANIP) over the last 1 years, with Dec 2014 value amounting to $7.6 million.

  • Ani Pharmaceuticals' Current Deferred Tax Assets was N/A to $8.3 million in Q3 2015 from the same period last year, while for Sep 2015 it was $8.3 million, marking a year-over-year change of. This contributed to the annual value of $7.6 million for FY2014, which is N/A change from last year.
  • As of FY2014, Ani Pharmaceuticals' Current Deferred Tax Assets stood at $7.6 million.
  • Ani Pharmaceuticals' Current Deferred Tax Assets' 5-year high stood at $7.6 million during FY2014, with a 5-year trough of $7.6 million in FY2014.
  • In the last 1 years, Ani Pharmaceuticals' Current Deferred Tax Assets had a median value of $7.6 million in 2014 and averaged $7.6 million.